Diverse entities are seemingly vested in STERIS plc (NYSE:STE), evidenced by recent activity. For instance, KBC Group NV, Swedbank AB, and Forsta AP Fonden have strengthened their holdings, while SG Americas Securities LLC, Running Oak Capital LLC, Perpetual Ltd, Foster Victor Wealth Advisors LLC, Fenimore Asset Management Inc, and others acquired additional shares. However, Oak Ridge Investments LLC and Crossmark Global Holdings Inc. documented reduced holdings.
STERIS recently declared a quarterly dividend of $0.57, maintaining its commitment to shareholder returns. Ahead of the upcoming Q3 FY2025 financial results' reveal, analysts anticipate positive earnings growth. Q2 2025 demonstrated strong revenue growth, even with margin pressures, and a revenue surge to $1.3B, led by the healthcare segment.
Steris has made notable moves, like the sale of its dental segment, undergoing restructuring that includes layoffs, and plans to sell its renal care business. Amid these changes, the company sustains growth in product offerings and strategic acquisitions, providing stability. Additionally, the company reported solid Q2 fiscal 2025 performance and is expected to announce its Q3 earnings soon.
Steris Plc STE News Analytics from Wed, 24 Jun 2015 07:00:00 GMT to Sat, 01 Feb 2025 09:25:45 GMT - Rating 8 - Innovation 6 - Information 7 - Rumor 4
